Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05902923 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05902923 · ClinicalTrials.gov record · last posted 2024-05-08

Investigating the Safety and Clinical Performance of Eight iVascular Devices for Endovascular Intervention in Renal, Iliac or Femoral Arteries

StatusRecruiting
PhaseNot specified
Started2023-08-01
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 8, 2024 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
The rationale of this study is to confirm and support the clinical safety and performance of any of these products in a real-world population of 209 patients who underwent an endovascular intervention within standard-of-care of the iliacofemoral artery and renal artery, using at least one of the investigational products from iVascular.

Amendment record 1 amendment on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended once since 2023-06-05. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2024-05-06
Status change Not Yet Recruiting→Recruitingv1
Trial Details
NCT Number NCT05902923
Lead Sponsor iVascular S.L.U.
Conditions Artery Disease
Enrollment 209 participants
Start Date 2023-08-01
Primary Completion 2025-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2024-05-08